Clinical, Histological, and Virological Parameters in HCV Chronic Carriers and Controls
| Patients . | Age/ Sex . | Neoplastic Disease . | Liver Disease . | HCV Status . | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibody Pattern (5-1-1/c100-3/c33/c22) . | PCR-Driven HCV RNA . | ||||||||||||||
| Type . | Histology . | Working Formulation . | Staging . | Histology . | Duration (yr) . | Serum/ Genotypes . | Lymph Nodes . | Liver Tissue . | BM . | ||||||
| 1 | 66/F | NHL | Follicular small cleaved cells | B | IIB | CH | 12 | − | − | + | + | +/1b | + | + | + |
| 2 | 77/F | NHL | Large cells immunoblastic | H | IIA | CH | 17 | − | − | − | + | +/2a | + | + | + |
| 3 | 59/M | NHL | Mixed: Small cleaved/large cells | G + A | IA | CIR | 21 | + | + | + | + | +/1b | + | + | + |
| 4 | 65/M | NHL | Diffuse large cells | G | IIA | CH | 11 | − | − | + | + | +/1b | + | + | + |
| 5 | 56/M | Colon carcinoma | Adenocarcinoma | — | T2, N2, M0 | CIR | 25 | − | + | + | + | +/1b | ND | + | ND |
| 6 | 61/M | Gastric carcinoma | Adenocarcinoma | — | T2, N1, M0 | CIR | 22 | + | + | + | + | +/1b | ND | + | ND |
| Controls | |||||||||||||||
| 1C | 59/F | NHL | Diffuse large cells | G | IIB | NNL | — | − | − | − | − | − | − | − | − |
| 2C | 69/F | NHL | Small lymphocytic | A | IB | ST | — | − | − | − | − | − | − | − | − |
| 3C | 75/M | NHL | Diffuse large cells | G | IIA | ST | — | − | − | − | − | − | − | − | − |
| 4C | 68/M | NHL | Follicular small cleaved cells | B | IIA | NNL | — | − | − | − | − | − | − | − | − |
| Patients . | Age/ Sex . | Neoplastic Disease . | Liver Disease . | HCV Status . | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antibody Pattern (5-1-1/c100-3/c33/c22) . | PCR-Driven HCV RNA . | ||||||||||||||
| Type . | Histology . | Working Formulation . | Staging . | Histology . | Duration (yr) . | Serum/ Genotypes . | Lymph Nodes . | Liver Tissue . | BM . | ||||||
| 1 | 66/F | NHL | Follicular small cleaved cells | B | IIB | CH | 12 | − | − | + | + | +/1b | + | + | + |
| 2 | 77/F | NHL | Large cells immunoblastic | H | IIA | CH | 17 | − | − | − | + | +/2a | + | + | + |
| 3 | 59/M | NHL | Mixed: Small cleaved/large cells | G + A | IA | CIR | 21 | + | + | + | + | +/1b | + | + | + |
| 4 | 65/M | NHL | Diffuse large cells | G | IIA | CH | 11 | − | − | + | + | +/1b | + | + | + |
| 5 | 56/M | Colon carcinoma | Adenocarcinoma | — | T2, N2, M0 | CIR | 25 | − | + | + | + | +/1b | ND | + | ND |
| 6 | 61/M | Gastric carcinoma | Adenocarcinoma | — | T2, N1, M0 | CIR | 22 | + | + | + | + | +/1b | ND | + | ND |
| Controls | |||||||||||||||
| 1C | 59/F | NHL | Diffuse large cells | G | IIB | NNL | — | − | − | − | − | − | − | − | − |
| 2C | 69/F | NHL | Small lymphocytic | A | IB | ST | — | − | − | − | − | − | − | − | − |
| 3C | 75/M | NHL | Diffuse large cells | G | IIA | ST | — | − | − | − | − | − | − | − | − |
| 4C | 68/M | NHL | Follicular small cleaved cells | B | IIA | NNL | — | − | − | − | − | − | − | − | − |
Abbreviations: CH, chronic hepatitis; NNL, near normal liver; CIR, cirrhosis; ST, steatosis; ND, not determined.